HomeTrading IdeasWhy the Next Cycle...

Why the Next Cycle in Global Equities Could Belong to Emerging Markets

Although there have been many false dawns over the past decade-and-a-half, there is good reason to believe that now is one of the best times in recent history to expect a turn in the long-term cycle of Emerging vs Developed market equity dominance.

Here’s why we should be looking at EM to start outperforming vs DM:

  • Valuations: on a variety of metrics, EM equities are trading at a major valuation discount vs developed market equities; this is an important starting point, but it’s also something that has been true for quite some time (so we also need to consider other factors when it comes to timing and conviction).

  • Allocations: as detailed in the bonus chart section below, investor allocations to EM equities are well below average, and represent major underweights vs the market cap weight of emerging markets.

  • Currencies: the has peaked for this cycle and is overvalued, meanwhile EMFX looks cheap and is turning up from a long downtrend (this will help EM equities outperform mathematically due to FX translation effects, but also due to financial conditions effects).

  • Sentiment: investor sentiment is still very skeptical on EM equities, in fact I imagine most people reading this are already coming up with arguments as to why I am wrong to be optimistic on EM 🙂 !

  • Cycles: EM central banks have been stimulating their economies, and many within this group have undergone a long period of stagnation and reform that will place them well to capitalize on the coming global economic upturn.

And then finally, let’s just take a look at the main chart this week — two key things should become obvious straightaway. First, there is a clear long-term uptrend in play, second, there are clear long-term cycles around that trend.

So, even just keeping it simple, and focusing on that chart, you can see that we have deviated significantly to the downside of that long-term uptrend line (the big opportunities/risks come when you deviate substantially above/below that trend) — AND the cycle looks to be turning up again.

And then ultimately, if we pair those technical chart observations with the various constructive fundamental observations, it sure starts to stack up.

We may well be on the cusp of a golden decade for emerging markets.

Key point:  Long-term investors should rethink their global equity allocations, placing a greater emphasis on global diversification, especially with regards to EM equities.

Bonus Chart 1 — EM Equity Allocations

This chart shows the market share of dedicated emerging market equity funds in both the US mutual fund market and ETF market — we can think of this as the implied allocation by investors to emerging market equities (in the aggregate).

So it’s fascinating then to see that mutual fund investors have an implied ~3% allocation to emerging market equities, while ETF investors are not much better; with 4% (which is down substantially from recent years, and a fraction of where it peaked at over 20% at the height of the post-08 recovery EM climax).

But really the key point is investors are running materially lower allocations than those seen over the past 20 years, and as you’ll see in the next chart, it’s also a fraction of the global market cap weight of EM equities (which is tracking just below 15%).

EM Equity Funds Percent All Equity Funds

Bonus Chart 2 — EM Equities Market Cap Weight

As noted, emerging market equities’ global market cap weight is hovering just below 15% — this is well below trend, and is at the low end of the range of the past 20-years. It’s also well below the GDP weight of emerging and developing countries (which is estimated by the IMF at 60%, or 41% excluding China, and that compares to advanced economies at 40%).

So the key point here is that this chart by itself is arguably another piece of evidence favoring EM equities given the deviation from trend (+undershooting of recent decades average), and given the disparity vs GDP weighting*, but perhaps most of all: even at the current lowish level it’s about 4x the typical investor’s allocation. That’s a massive underweight that investors in the aggregate are running.

All that’s needed is an excuse, a catalyst, a reason to reallocate, and we could see something really special here — something that only happens about once a decade (a shift and turn in the decadal cycles of relative performance in global equities).

Emerging Markets Percent Global Equity Market Cap

*p.s. yes, there are good reasons why EM is tracking below its GDP weight, and that DM is tracking above its GDP weight, but even if you assume it doesn’t get all the way there, it still has a lot of room to move. Also as a sidenote, the US (record high) market-cap-to-GDP-ratio is basically another datapoint affirming overvaluation there.

Most Popular

More from Author

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline...

Read Now

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...

Dow Jones Forecast: Political Tensions and Tariff Risks Weigh on Outlook

US futures are rising on Monday after the extended holiday weekend. Uncertainty surrounding U.S. trade tariff policies are keeping investors cautious, whilst Tesla (NASDAQ:) is taking a hit after Musk announced plans to launch a political party.US Futures 0.78% at 44839 0.7% at 6266 0.53% at 23977In...

Why Is Apogee Therapeutics Stock Soaring On Monday? – Apogee Therapeutics (NASDAQ:APGE)

Apogee Therapeutics Inc. APGE stock is experiencing a significant surge, trading almost 29% higher in premarket on Monday.This substantial increase in stock price follows the release of positive 16-week data from Part A of the Phase 2 APEX clinical trial of APG777, an anti-IL-13 antibody, for moderate-to-severe...

EUR/USD Slips as Trade Talks Stall and Retail Sales Disappoint

falls with trade talks in focus and following weak retail sales. Oil slips after OPEC+ increases output by more than expected.EUR/USD Falls With Trade Talks in Focus and After Weak Retail SalesThe EU and the US are nearing a framework agreement Eurozone retail sales fell -0.7% MoM EUR/USD...

Oil Prices Expected to Stay Under $70

Analysts widely expect oil prices to remain below $70 per barrel for the remainder of 2025, primarily due to global oversupply and ongoing uncertainties regarding demand. Despite heightened geopolitical tensions in the Middle East, these factors are not anticipated to significantly drive up oil prices unless direct supply...